Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2012 Apr;50(4):1437–1439. doi: 10.1128/JCM.06746-11

Comparative Study Using Phenotypic, Genotypic, and Proteomics Methods for Identification of Coagulase-Negative Staphylococci

Anne J M Loonen a,b,c,d, Arjan R Jansz a, Jeandery N B Bergland a, Marion Valkenburg a, Petra F G Wolffs c, Adriaan J C van den Brule a,b,d,
PMCID: PMC3318536  PMID: 22238435

Abstract

Five methods were compared to determine the most accurate method for identification of coagulase-negative staphylococci (CoNS) (n = 142 strains). Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) showed the best results for rapid and accurate CoNS differentiation (99.3% of strains correctly identified). An alternative to this approach could be Vitek2 combined with partial tuf gene sequencing (100% of strains correctly identified when both methods are performed simultaneously).

TEXT

Coagulase-negative staphylococci (CoNS) have emerged as significant pathogens and are mainly found in hospitalized immunocompromised patients, often with indwelling or implanted medical devices (10, 13, 15, 18, 22). Most infections are hospital acquired, and CoNS infections can result in several diseases, including bloodstream infection, endocarditis, mediastinitis, meningitis, urinary tract infections (Staphylococcus saprophyticus), and medical-device-related infections (1, 8, 12, 18, 19, 22). Accurate identification of CoNS is important when CoNS are isolated from multiple blood cultures of 1 patient. Many CoNS are described to be resistant to multiple antibiotics (11, 14, 17, 19). Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) is a relatively new technique that allows examination of protein profiles from bacteria, and this technique has been shown to work in a fast and accurate manner (4, 6, 7, 21).

In the present comparative study, five methods for differentiation of CoNS were compared, i.e., Vitek2 (Gram Positive card REF 21342; bioMérieux), the ID 32 Staph strip (bioMérieux), partial 16S rRNA gene sequencing (MicroSeq; Applied Biosystems), partial tuf gene sequencing (in-house), and MALDI-TOF MS (Bruker Daltonics), on the same set of CoNS strains in order to find the most suitable method available today for identification of staphylococci.

A total of 142 CoNS strains were included in this study. Isolates were derived from clinical cultures (n = 117), and 25 reference strains from the American Type Culture Collection (ATCC) and the National Institute for Health and Environment (RIVM; Bilthoven, The Netherlands) were included. The clinical isolates were selected from positive blood cultures (two or more positive cultures from 1 patient), urinary tract infections (S. saprophyticus), or deep-seated infections. The CoNS species name that was found with ≥3 of the 5 used methods was chosen as the true CoNS species name (referred to here as the true ID). When only 2 methods resulted in similar true IDs (4/142 cases [2.8%]), tuf sequencing was selected as the most reliable method, as the result for 16S rRNA gene sequencing was noninformative (Staphylococcus spp.).

CoNS strains were cultured overnight at 35°C on blood plates (made in-house). The phenotypic methods Vitek2 (bioMérieux, Marcy l'Etoile, France) and ID 32 Staph (bioMérieux, Marcy l'Etoile, France) were both performed as described by the manufacturer.

DNA for sequencing was isolated from 2 McFarland bacterial suspensions by heating them (for 10 min at 95°C). The 16S rRNA gene primers from the MicroSeq kit were used, and these primers amplify approximately the first 500 bp of the gene (Applied Biosystems, Foster City, CA). The tuf forward primer (tuf_32_FW) was described previously (16), and the tuf reverse primer (tuf_512_RV; 5′-CAGCTTCAGCGTAGTCTAATAATTTACG-3′) was designed for this study. The positions of the tuf primers were derived from the Staphylococcus aureus tuf gene sequence (GenBank accession no. AF298796), and these primers amplify a 480-bp fragment. The tuf primers were obtained from Eurogentec (Liège, Belgium). PCR was performed according to standard procedures. Sequencing was performed using BigDye XTerminator sequencing mix 3.1 (Applied Biosystems, Foster City, CA) and ran on an ABI Prism 310 genetic analyzer (Applied Biosystems, Foster City, CA). The 16S DNA sequences were analyzed by using MicroSeqID Analysis software (Applied Biosystems, Foster City, CA). The tuf DNA sequences were analyzed by using the Basic Local Assignment Search Tool (BLAST; http://blast.ncbi.nlm.nih.gov/Blast.cgi).

For MALDI-TOF MS (Bruker Daltonics) analysis, 1 colony of each CoNS strain was spotted with a sterile wooden stick, in duplicate, on the polished steel target plate. Samples that could not be identified directly by MALDI-TOF MS were retested after pretreatment (n = 5 clinical CoNS strains [1 strain each of Staphylococcus hominis, S. epidermidis, S. cohnii, S. schleiferi, and S. saprophyticus]) as described by van Veen et al. (21). However, in this study, formic acid (70%) and acetonitrile were added according to pellet size at a 1:1 ratio. BioTyper database version V3 1.1.0_3476-3740 was used as a reference.

The results (Table 1) for the phenotypic identification methods used in this study indicate that Vitek2 performs best, with a correct-identification rate of 92.3%, compared to 85.9% for ID 32 Staph. The acceptance criteria for all results are described in the footnote to Table 1.

Table 1.

Summary of the performance of methods used for differentiation of CoNSa

True organism No. of strains No. of strains identified by indicated method
ID 32 Staph
Vitek2
16S sequencing
tuf sequencing
MALDI-TOF MS
Correctly Incorrectly ND Correctly Incorrectly ND Correctly Incorrectly ND Correctly Incorrectly ND Correctly Incorrectly ND
S. capitis 13 12 1 12 1 11 2 13 13
S. caprae 1 1 1 1 1 1
S. cohnii 1 1 1 1 1 1
S. epidermidis 29 24 5 26 3 24 5 29 29
S. haemolyticus 18 18 16 2 13 5 18 18
S. hominis 22 19 3 21 1 17 5 22 21 1
S. lentus 1 1 1 1 1 1
S. lugdunensis 11 11 11 9 2 11 11
S. pasteuri 1 1 1 1 1 1
S. pettenfoferi 2 2 2 2 2 2
S. saprophyticus 12 12 12 8 4 12 12
S. schleiferi 10 4 6 10 4 6 10 10
S. sciuri 5 5 5 5 5 5
S. simulans 6 6 5 1 6 6 6
S. warneri 10 9 1 10 7 3 10 10
Total (%) 142 (100) 122 (85.9) 20 (14.1) 0 (0) 131 (92.3) 11 (7.7) 0 (0) 100 (70.4) 42 (29.6) 0 (0) 132 (93) 10 (7) 0 (0) 141 (99.3) 1 (0.7) 0 (0)
a

The acceptance criteria for the results were as follows: for ID 32 Staph, a score of ≥70%; for Vitek2, a score of ≥70% (in-house validation); for tuf sequencing, a species name provided by BLAST showing a ≥99% sequence match (identity) and a mismatch of at least a 1 nucleotide with the second hit; for 16S sequencing, a first hit showing a ≥99% sequence match (identity) and a second hit having a mismatch of at least 1 nucleotide (MicroSeq software); for MALDI-TOF MS, a hit rate of ≥1.7 (however, <2 was considered reliable to the species level if the first and second database matches resulted in the same strain name; ideally, ≥2 reference spectra need to be available in the database, and scores of ≥2 were considered reliable to the species level). ND, not determined.

With the use of 16S rRNA gene and tuf sequencing, 70.4% and 93% of the CoNS strains, respectively, were correctly identified. When the first hit with the MicroSeqID database was selected as the true finding (disregarding analysis rules), then 137 out of 142 strains were correctly identified (96.5%). Application of the CLSI guidelines (23), which are stricter than those used in this study, will lead to even more results that are noninformative (Staphylococcus spp.) and thus incorrect identifications with 16S sequencing in this study. Whole-16S-gene sequencing will improve the Staphylococcus species differentiation ability of this specific gene but will also increase the number of required sequence reactions and consequently slightly increase costs and, in some cases, time-to results. Becker et al. (2) showed that with the use of the quality-controlled Ribosomal Sequence Database (RIDOM), identification of staphylococci improved from 83.6% to 98.2%, compared to the results obtained with the NCBI database. With the use of the RIDOM database, the results obtained in this study might positively change as well. However, tuf gene sequencing resulted in more informative data (species name) and was also in concordance with MALDI-TOF MS results. Although all Staphylococcus warneri strains (n = 10) resulted in incorrect identification with tuf gene sequencing, due to high homology to S. pasteuri, extensive analysis of S. pasteuri and S. warneri strains might solve the current problems. Therefore, the tuf gene seems more suitable for identification of staphylococci, as described by others (5, 9).

The MALDI-TOF MS data obtained in this evaluation indicate the superiority in identification of CoNS, as 99.3% of the strains were correctly identified with this method. Strains were spotted in duplicate and resulted in the same identification (strain name). The database (V3 1.1.0_3476-3740) used for this study contained the following numbers of reference spectra per tested CoNS species: Staphylococcus capitis, 6; S. caprae, 1; S. cohnii, 5; S. epidermidis, 9; S. haemolyticus, 8; S. hominis, 6; S. lentus, 2; S. lugdunensis, 5; S. pasteuri, 2; S. pettenkoferi, 4; S. saprophyticus, 8; S. schleiferi, 6; S. sciuri, 4; S. simulans, 5; and S. warneri, 4. For S. caprae, only 1 reference spectrum is available, and duplicate measurement indicated S. caprae (hit 1; score, 1.853). The second hit for this CoNS species indicated S. epidermidis twice (<1.5). For the proposed result acceptance criteria for MALDI-TOF MS to be used, the number of reference spectra per CoNS strain ideally needs to be ≥2. However, as hit 2 provided an unreliable score for S. epidermidis, we considered the S. caprae result the correct identification. On average, there was a 4.82% difference in score value between hits 1 and 2. The combination of MALDI-TOF MS with tuf gene sequencing resulted in a correct-identification rate of 100%.

The 25 reference strains used in this study showed that different misidentifications occurred with the investigated methods. With the 16S sequencing protocol, 9/25 reference strains could not be identified to the species level (36%). With Vitek2, ID 32 Staph, and tuf sequencing, 2/25 reference strains were misidentified (8%). MALDI-TOF MS resulted in correct identification of all reference strains. MALDI-TOF MS has been investigated by others in relation to Staphylococcus species identification directly from agar plates (3, 6, 7, 20), and the correct-identification rates range from 74.2% to 99.3%. The data obtained in this study are comparable with data reported by Spanu et al. (20) and Dubois et al. (6), in which a sensitivity of 99.3% was found. In this study, only one S. hominis strain could not be identified with MALDI-TOF MS (Table 1), for unknown reasons.

Sequencing of the partial 16S gene resulted in the most clinically relevant misidentifications, as both S. lugdunensis and S. saprophyticus were not correctly identified.

In conclusion, this is one of the most extensive comparative studies for CoNS identification. The results obtained in this study demonstrate the good performance of MALDI-TOF MS for identification of CoNS, as a correct-identification rate of 99.3% was achieved with this method. tuf gene sequencing is the most suitable substitute for MALDI-TOF MS. When cheap, fast, and accurate identification of CoNS is needed, the usage of MALDI-TOF MS is the method of choice and, when necessary, the tuf gene can be sequenced. As an alternative method, due to the fact that not every diagnostic microbiology laboratory has access to a MALDI-TOF MS system, Vitek2 combined with tuf sequencing is suggested as an accurate approach for CoNS differentiation.

ACKNOWLEDGMENTS

We thank Jitske Stalpers and Christel van Herk for their technical support.

We declare that we have no conflict of interest.

Footnotes

Published ahead of print 11 January 2012

REFERENCES

  • 1. Bearman GM, Wenzel RP. 2005. Bacteremias: a leading cause of death. Arch. Med. Res. 36:646–659 [DOI] [PubMed] [Google Scholar]
  • 2. Becker K, et al. 2004. Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J. Clin. Microbiol. 42:4988–4995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Bergeron M, et al. 2011. Species identification of staphylococci by amplification and sequencing of the tuf gene compared to the gap gene and by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Eur. J. Clin. Microbiol. Infect. Dis. 30:343–354 [DOI] [PubMed] [Google Scholar]
  • 4. Carbonnelle E, et al. 2007. Rapid identification of staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 45:2156–2161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Carpaij N, Willems RJ, Bonten MJ, Fluit AC. 2011. Comparison of the identification of coagulase-negative staphylococci by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tuf sequencing. Eur. J. Clin. Microbiol. Infect. Dis. 30:1169–1172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Dubois D, et al. 2010. Identification of a variety of Staphylococcus species by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 48:941–945 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Dupont C, et al. 2010. Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin. Microbiol. Infect. 16:998–1004 [DOI] [PubMed] [Google Scholar]
  • 8. Garcia P, et al. 2004. Coagulase-negative staphylococci: clinical, microbiological and molecular features to predict true bacteraemia. J. Med. Microbiol. 53:67–72 [DOI] [PubMed] [Google Scholar]
  • 9. Heikens E, Fleer A, Paauw A, Florijn A, Fluit AC. 2005. Comparison of genotypic and phenotypic methods for species-level identification of clinical isolates of coagulase-negative staphylococci. J. Clin. Microbiol. 43:2286–2290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Hira V, et al. 2007. Clinical and molecular epidemiologic characteristics of coagulase-negative staphylococcal bloodstream infections in intensive care neonates. Pediatr. Infect. Dis. J. 26:607–612 [DOI] [PubMed] [Google Scholar]
  • 11. Huebner J, Goldmann DA. 1999. Coagulase-negative staphylococci: role as pathogens. Annu. Rev. Med. 50:223–236 [DOI] [PubMed] [Google Scholar]
  • 12. Karchmer AW. 2000. Nosocomial bloodstream infections: organisms, risk factors, and implications. Clin. Infect. Dis. 31(Suppl. 4):S139–S143 [DOI] [PubMed] [Google Scholar]
  • 13. Kloos WE, Bannerman TL. 1994. Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev. 7:117–140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Koksal F, Yasar H, Samasti M. 2009. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. Microbiol. Res. 164:404–410 [DOI] [PubMed] [Google Scholar]
  • 15. Krediet TG, et al. 2004. Molecular epidemiology of coagulase-negative staphylococci causing sepsis in a neonatal intensive care unit over an 11-year period. J. Clin. Microbiol. 42:992–995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Loonen AJ, et al. 2011. Acceleration of the direct identification of Staphylococcus aureus versus coagulase-negative staphylococci from blood culture material: a comparison of six bacterial DNA extraction methods. Eur. J. Clin. Microbiol. Infect. Dis. 30:337–342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Natoli S, et al. 2009. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. BMC Infect. Dis. 9:83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Pfaller MA, Herwaldt LA. 1988. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin. Microbiol. Rev. 1:281–299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Piette A, Verschraegen G. 2009. Role of coagulase-negative staphylococci in human disease. Vet. Microbiol. 134:45–54 [DOI] [PubMed] [Google Scholar]
  • 20. Spanu T, et al. 2011. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to rpoB gene sequencing for species identification of bloodstream infection staphylococcal isolates. Clin. Microbiol. Infect. 17:44–49 [DOI] [PubMed] [Google Scholar]
  • 21. van Veen SQ, Claas EC, Kuijper EJ. 2010. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization–time of flight mass spectrometry in conventional medical microbiology laboratories. J. Clin. Microbiol. 48:900–907 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. von Eiff C, Jansen B, Kohnen W, Becker K. 2005. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 65:179–214 [DOI] [PubMed] [Google Scholar]
  • 23. Wayne PA. 2008. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing, p. 26–30 Approved guideline. CLSI document MM18-A Clinical and Laboratory Standards Institute, Wayne, PA [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES